STAGE III PROSTATE CANCER AJCC V8
Clinical trials for STAGE III PROSTATE CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III PROSTATE CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III PROSTATE CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Precision proton beams target prostate cancer with fewer side effects
Disease control Recruiting nowThis study is testing whether proton radiation therapy can treat high-risk prostate cancer while causing fewer digestive and urinary side effects than traditional radiation. Researchers will treat 30 patients with advanced prostate cancer using precisely targeted proton beams tha…
Matched conditions: STAGE III PROSTATE CANCER AJCC V8
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Apr 01, 2026 18:41 UTC
-
Daily radiation Tune-Ups aim to spare men from side effects
Disease control Recruiting nowThis study is testing whether adjusting radiation treatment plans daily using real-time MRI or CT scans can reduce side effects for men with localized prostate cancer. Researchers will compare this 'adaptive' approach to standard radiation that uses a fixed plan. The goal is to s…
Matched conditions: STAGE III PROSTATE CANCER AJCC V8
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Shorter radiation course tested for returning prostate cancer
Disease control Recruiting nowThis study compares two types of radiation therapy for men whose prostate cancer has returned or spread to a few spots after initial surgery. It tests if a shorter, more precise 5-treatment course (SBRT) works as well as a longer 20-treatment course, with potentially fewer side e…
Matched conditions: STAGE III PROSTATE CANCER AJCC V8
Phase: PHASE3 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Heart attack risk in prostate cancer treatment: new trial seeks safer option
Disease control Recruiting nowThis study aims to find out which of two standard hormone therapy combinations is safer for the heart when treating advanced prostate cancer. It will enroll 72 men who are about to start radiation therapy and need hormone treatment. Researchers will use special heart scans and bl…
Matched conditions: STAGE III PROSTATE CANCER AJCC V8
Phase: PHASE3 • Sponsor: Emory University • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New trial tests if switching PARP inhibitors can help control advanced cancers
Disease control Recruiting nowThis study is testing whether the drug talazoparib can help control advanced cancers in patients whose tumors have specific mutations in genes that help repair DNA damage. It is enrolling 36 adults with various advanced solid tumors (like breast, ovarian, prostate, pancreatic, an…
Matched conditions: STAGE III PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug combo tested to keep aggressive prostate cancer in check
Disease control Recruiting nowThis study is testing if adding a drug called niraparib to standard hormone therapy after radiation treatment works better at controlling high-risk prostate cancer that is still in the prostate area or nearby lymph nodes. It will enroll about 200 men. The goal is to see if this c…
Matched conditions: STAGE III PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Major trial aims to stop prostate Cancer's spread after surgery
Disease control Recruiting nowThis study is for men whose prostate cancer has spread to nearby lymph nodes after surgery. It tests if adding a drug called apalutamide to the usual hormone and radiation therapy can better control the cancer and prevent it from spreading further. The goal is to see if this stro…
Matched conditions: STAGE III PROSTATE CANCER AJCC V8
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Prostate cancer drug side effects Head-to-Head trial
Disease control Recruiting nowThis study compares how well patients tolerate two different drug treatments for advanced prostate cancer. Researchers will follow 75 men taking either abiraterone with prednisone or darolutamide alone for one year. The main goal is to see which treatment causes fewer serious sid…
Matched conditions: STAGE III PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Cancer care comes home: study tests if treatment outside clinic is better
Disease control Recruiting nowThis study is testing whether giving prostate cancer treatment at home is as safe and effective as receiving it in a clinic. Black men with advanced prostate cancer will receive part of their standard treatment at home with remote monitoring. Researchers want to see if home treat…
Matched conditions: STAGE III PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Vitamin d trial aims to stop bone loss in prostate cancer patients
Disease control Recruiting nowThis study is testing whether taking a high weekly dose of vitamin D can help protect bone strength in older men with prostate cancer who are receiving hormone therapy. Hormone therapy can weaken bones, increasing the risk of fractures and falls. Researchers will compare the bone…
Matched conditions: STAGE III PROSTATE CANCER AJCC V8
Phase: PHASE3 • Sponsor: University of Rochester • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Shorter radiation course tested for prostate cancer
Disease control Recruiting nowThis study is testing whether a shorter, more precise radiation treatment (2 sessions) works as well as the standard longer treatment (5 sessions) for prostate cancer that hasn't spread. The goal is to see if the shorter treatment can control the cancer while causing fewer side e…
Matched conditions: STAGE III PROSTATE CANCER AJCC V8
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
Radiation breakthrough aims to spare men from treatment side effects
Disease control Recruiting nowThis study is testing a more precise form of radiation therapy for prostate cancer that hasn't spread. It uses real-time imaging to track the prostate's movement during treatment, allowing doctors to deliver radiation more accurately. The goal is to reduce common side effects lik…
Matched conditions: STAGE III PROSTATE CANCER AJCC V8
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC
-
Two weeks vs. two months: race to find faster prostate cancer treatment
Disease control Recruiting nowThis large trial is comparing two different radiation schedules for men with high-risk prostate cancer. It will test if a much shorter, more intense treatment (5 sessions over 2 weeks) is as effective at preventing the cancer from spreading as the standard, longer course (20-45 s…
Matched conditions: STAGE III PROSTATE CANCER AJCC V8
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Mar 04, 2026 15:30 UTC
-
New scan could spare prostate cancer patients unnecessary surgery
Diagnosis Recruiting nowThis study is testing a new type of imaging scan to see if it can accurately tell whether prostate cancer has spread to nearby lymph nodes. If successful, this scan could help doctors decide which patients truly need to have their lymph nodes removed during prostate cancer surger…
Matched conditions: STAGE III PROSTATE CANCER AJCC V8
Phase: NA • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Mar 27, 2026 12:40 UTC
-
Hormone shot could sharpen prostate cancer scans, find hidden disease
Diagnosis Recruiting nowThis study is testing if a short course of hormone-blocking pills can make prostate cancer cells 'light up' more brightly on a special imaging scan. The goal is to help doctors see smaller or hidden areas of cancer that have spread, particularly to lymph nodes, in men with high-r…
Matched conditions: STAGE III PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Feb 18, 2026 14:06 UTC
-
Can golf swing help men battle prostate cancer side effects?
Symptom relief Recruiting nowThis study is testing whether a 10-week supervised golf program can help improve the well-being of prostate cancer survivors who are on hormone therapy. Researchers want to see if regular golf practice can improve physical ability, mood, and overall quality of life for these men.…
Matched conditions: STAGE III PROSTATE CANCER AJCC V8
Phase: NA • Sponsor: University of Southern California • Aim: Symptom relief
Last updated Apr 01, 2026 14:43 UTC
-
Glowing glasses aim to lift spirits and ease exhaustion for prostate cancer patients
Symptom relief Recruiting nowThis study is testing whether wearing bright white light therapy glasses can help reduce severe tiredness and low mood in men with advanced prostate cancer who are receiving powerful hormone-based treatments. The main goal is to see if starting the light glasses right away is bet…
Matched conditions: STAGE III PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Mar 30, 2026 14:29 UTC
-
New nerve wrap aims to protect Men's quality of life after prostate surgery
Symptom relief Recruiting nowThis study is testing whether wrapping delicate nerves with a special protective tissue during prostate cancer surgery can help men recover better. The goal is to see if this wrap can reduce common side effects like erectile dysfunction and urinary incontinence after the operatio…
Matched conditions: STAGE III PROSTATE CANCER AJCC V8
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Mar 23, 2026 15:14 UTC
-
Can a buddy system bridge the gap in cancer care?
Knowledge-focused Recruiting nowThis study is testing whether having a trained peer navigator helps African American men with advanced prostate cancer understand and go through genetic testing better than standard care alone. Genetic testing is important for treatment decisions, but many men face barriers like …
Matched conditions: STAGE III PROSTATE CANCER AJCC V8
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC